4//SEC Filing
Cole Douglas G. 4
Accession 0001714899-22-000095
CIK 0001714899other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 8:09 PM ET
Size
7.6 KB
Accession
0001714899-22-000095
Insider Transaction Report
Form 4
Cole Douglas G.
Director
Transactions
- Award
Common Stock
2022-06-02+5,986→ 22,348 total - Award
Stock Option (right to buy)
2022-06-02+17,959→ 17,959 totalExercise: $24.27Exp: 2032-06-02→ Common Stock (17,959 underlying)
Footnotes (4)
- [F1]Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
- [F2]Includes 11,035 shares received in prior distributions-in-kind made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.
- [F3]Includes 5,986 unvested restricted stock units.
- [F4]100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001486373
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 8:09 PM ET
- Size
- 7.6 KB